Catalyst Wire Dossier Catalyst Wire Dossier

asunercept

asunercept · Apogenix AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for asunercept, covering 2022-01-14 to 2023-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease [Phase 3]

See pricing